Cholecystokinin-33 is more effective than cholecystokinin-8 in inhibiting food intake and in stimulating the myenteric plexus and dorsal vagal complex

Brain Research

Volumn 1205, Issue , 2008, Pages 27-35

  Cooper, Marvis S ^a   Reeve Jr , Joseph R ^b   Abdalla, Mohamed O ^a   Moyer, Laura ^a   Raboin, Shannon J ^a   Green, Gary M ^c   Sayegh, Ayman I ^a  

^a Nursing and Allied Health   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

CCK 58; Endocrine; Endogenous CCK; Enteric nervous system; Fos; Paracrine; Satiety; Submucosal plexus

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; PROTEIN FOS; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; DUODENUM; FOOD DEPRIVATION; FOOD INTAKE; IMMUNOREACTIVITY; INTESTINE INNERVATION; MALE; MEAL; MYENTERIC PLEXUS; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SATIETY; VAGUS NERVE DORSAL NUCLEUS;

ANIMALS; APPETITE DEPRESSANTS; CELL COUNT; CHOLECYSTOKININ; EATING; IMMUNOHISTOCHEMISTRY; MALE; MYENTERIC PLEXUS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SOLITARY NUCLEUS; VAGUS NERVE;

RATTUS;

EID: 41949083294     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.02.012     Document Type: Article

References (58)

1. Ahren B., Pettersson M., Uvnas-Moberg K., Gutniak M., and Efendic S. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. Diabetes Res. Clin. Pract. 13 (1991) 153-161
2. Byrnes D.J., Borody T., Daskalopoulos G., Boyle M., and Benn I. Cholecystokinin and gallbladder contraction: effect of CCK infusion. Peptides 2 Suppl 2 (1981) 259-262
3. Byrnes D.J., Henderson L., Borody T., and Rehfeld J.F. Radioimmunoassay of cholecystokinin in human plasma. Clin. Chim. Acta 111 (1981) 81-89
4. Corwin R.L., Gibbs J., and Smith G.P. Increased food intake after type A but not type B cholecystokinin receptor blockade. Physiol. Behav. 50 (1991) 255-258
5. Dale W.E., Turkelson C.M., and Solomon T.E. Role of cholecystokinin in intestinal phase and meal-induced pancreatic secretion. Am. J. Physiol. 257 (1989) G782-G790
6. Debas H.T., and Grossman M.I. Pure cholecystokinin: pancreatic protein and bicarbonate response. Digestion 9 (1973) 469-481
7. Dockray G.J. The action of gastrin and cholecystokinin-related peptides on pancreatic secretion in the rat. Q. J. Exp. Physiol. Cogn. Med. Sci. 58 (1973) 163-169
8. Doi R., Inoue K., Kogire M., Sumi S., Yun M., Futaki S., Fujii N., Yajima H., and Tobe T. Effect of synthetic human cholecystokinin-33 on exocrine pancreas. Biochem. Biophys. Res. Commun. 150 (1988) 1251-1255
9. Dragunow M., and Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods 29 (1989) 261-265
10. Eisen S., Phillips R.J., Geary N., Baronowsky E.A., Powley T.L., and Smith G.P. Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation. Am. J. Physiol., Regul. Integr. Comp. Physiol. 289 (2005) R456-R462
11. Eisen S., Rushing P.A., Geary N., and Smith G.P. The satiating effect of CCK-33 is produced by hormonal and paracrine mechanisms, but CCK-8 acts through only a paracrine mechanism in the rat. Appetite 49 (2007) 289
12. Eysselein V.E., Bottcher W., Kauffman Jr. G.L., and Walsh J.H. Molecular heterogeneity of canine cholecystokinin in portal and peripheral plasma. Regul. Pept. 9 (1984) 173-185
13. Eysselein V.E., Maxwell V., Reedy T., Wunsch E., and Walsh J.H. Similar acid stimulatory potencies of synthetic human big and little gastrins in man. J. Clin. Invest. 73 (1984) 1284-1290
14. Fraser K.A., and Davison J.S. Cholecystokinin-induced c-fos expression in the rat brain stem is influenced by vagal nerve integrity. Exp. Physiol. 77 (1992) 225-228
15. Gibbs J., Young R.C., and Smith G.P. Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol. 84 (1973) 488-495
16. Gores G.J., LaRusso N.F., and Miller L.J. Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction. Am. J. Physiol. 250 (1986) G344-G349
17. Gores G.J., Miller L.J., and LaRusso N.F. Hepatic processing of cholecystokinin peptides. II. Cellular metabolism, transport, and biliary excretion. Am. J. Physiol. 250 (1986) G350-G356
18. Gores G.J., Kost L.J., Miller L.J., and LaRusso N.F. Processing of cholecystokinin by isolated liver cells. Am. J. Physiol. 257 (1989) G242-G248
19. Gulley S., Sharma S.K., Mansour M., Sullivan C.N., Moran T.H., and Sayegh A.I. Strain differences in myenteric neuron number and CCK(1) receptor mRNA expression may account for differences in CCK induced c-Fos activation. Brain Res. 1058 (2005) 109-119
20. Gulley S., Sharma S.K., Moran T.H., and Sayegh A.I. Cholecystokinin-8 increases Fos-like immunoreactivity in the brainstem and myenteric neurons of rats through CCK1 receptors. Peptides 26 (2005) 1617-1622
21. Harper A.A., and Raper H.S. Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine. J. Physiol. 102 (1943) 115-125
22. Hewson G., Leighton G.E., Hill R.G., and Hughes J. The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin. Br. J. Pharmacol. 93 (1988) 79-84
23. Hoffmann P., Eberlein G.A., Reeve Jr. J.R., Bunte R.H., Grandt D., Goebell H., and Eysselein V.E. Comparison of clearance and metabolism of infused cholecystokinins 8 and 58 in dogs. Gastroenterology 105 (1993) 1732-1736
24. Ivy A.C., and Oldberg E.A. A hormone mechanism for gallbladder contraction and evacuation. Am. J. Physiol. 86 (1928) 599-613
25. Jansen J.B., and Lamers C.B. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin. Chim. Acta 131 (1983) 305-316
26. Jansen J.B., and Lamers C.B. Radioimmunoassay of cholecystokinin: production and evaluation of antibodies. J. Clin. Chem. Clin. Biochem. 21 (1983) 387-394
27. Jensen S.L., Rehfeld J.F., Holst J.J., Nielsen O.V., Fahrenkrug J., and Schaffalitzky de Muckadell O.B. Secretory effects of cholecystokinins on the isolated perfused porcine pancreas. Acta Physiol. Scand. 111 (1981) 225-231
28. Keire D.A., Solomon T.E., and Reeve Jr. J.R. NMR evidence for different conformations of the bioactive region of rat CCK-8 and CCK-58. Biochem. Biophys. Res. Commun. 293 (2002) 1014-1020
29. Konturek S.J., Tasler J., Bilski J., de Jong A.J., Jansen J.B., and Lamers C.B. Physiological role and localization of cholecystokinin release in dogs. Am. J. Physiol. 250 (1986) G391-G397
30. Kost L.J., Gores G.J., Sayles J.M., Miller L.J., Lemasters J.J., Herman B., and LaRusso N.F. Lack of metabolic effects of cholecystokinin on hepatocytes. Hepatology 12 (1990) 301-305
31. Liddle R.A., Goldfine I.D., and Williams J.A. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology 87 (1984) 542-549
32. Liddle R.A., Elashoff J., and Reeve Jr. J.R. Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini. Peptides 7 (1986) 723-727
33. Lilja P., Fagan C.J., Wiener I., Inoue K., Watson L.C., Rayford P.L., and Thompson J.C. Infusion of pure cholecystokinin in humans. Correlation between plasma concentrations of cholecystokinin and gallbladder size. Gastroenterology 83 (1982) 256-261
34. Medeiros M.S., and Turner A.J. Post-secretory processing of regulatory peptides: the pancreatic polypeptide family as a model example. Biochimie 76 (1994) 283-287
35. Melville L.D., Smith G.P., and Gibbs J. Comparison of the satiating potencies of cholecystokinin-33 and cholecystokinin-8. Pharmacol. Biochem. Behav. 45 (1993) 85-87
36. Mutt V., and Jorpes J.E. Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur. J. Biochem. 6 (1968) 156-162
37. Mutt V., and Jorpes E. Hormonal polypeptides of the upper intestine. Biochem. J. 125 (1971) 57P-58P
38. Paxinos G., and Watson C. The Rat Brain in Sterotaxic Coordinates (1997), Academic Press, San Diego Vol.
39. Raboin S.J., Gulley S., Henley S.C., Chan W.C., Esdaile A.R., Jackson C.A., Billups L.H., and Sayegh A.I. Effect of sympathectomy and demedullation on increased myenteric and dorsal vagal complex Fos-like immunoreactivity by cholecystokinin-8. Regul. Pept. 134 (2006) 141-148
40. Raboin S.J., Gulley S., Henley S.C., Chan W.C., Esdaile A.R., and Sayegh A.I. Atropine methyl nitrate increases myenteric but not dorsal vagal complex Fos-like immunoreactivity in the rat. Physiol. Behav. 88 (2006) 448-452
41. Raboin S.J., Gulley S., Henley S.C., Chang W.C., Esdaile A.R., Jackson C.A., and Sayegh A.I. Effect of adrenalectomy on cholecystokinin-8-induced Fos-like immunoreactivity in myenteric neurons and the dorsal vagal complex in rats. Am. J. Vet. Res. 67 (2006) 1552-1556
42. Reeve Jr. J.R., McVey D.C., Bunnett N.W., Solomon T.E., Keire D.A., Ho F.J., Davis M.T., Lee T.D., Shively J.E., and Vigna S.R. Differences in receptor binding and stability to enzymatic digestion between CCK-8 and CCK-58. Pancreas 25 (2002) e50-e55
43. Reidelberger R.D., and O'Rourke M.F. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats. Am. J. Physiol. 257 (1989) R1512-R1518
44. Sagar S.M., Sharp F.R., and Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240 (1988) 1328-1331
45. Sakamoto T., Fujimura M., Newman J., Zhu X.G., Greeley Jr. G.H., and Thompson J.C. Comparison of hepatic elimination of different forms of cholecystokinin in dogs. Bioassay and radioimmunoassay comparisons of cholecystokinin-8-sulfate and -33-sulfate. J. Clin. Invest. 75 (1985) 280-285
46. Sankaran H., Goldfine I.D., Bailey A., Licko V., and Williams J.A. Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini. Am. J. Physiol. 242 (1982) G250-G257
47. Sayegh A.I., and Ritter R.C. CCK-A receptor activation induces fos expression in myenteric neurons of rat small intestine. Regul. Pept. 88 (2000) 75-81
48. Sayegh A.I., and Ritter R.C. Cholecystokinin activates specific enteric neurons in the rat small intestine. Peptides 24 (2003) 237-244
49. Sayegh A.I., and Ritter R.C. Morphology and distribution of nitric oxide synthase-, neurokinin-1 receptor-, calretinin-, calbindin-, and neurofilament-M-immunoreactive neurons in the myenteric and submucosal plexuses of the rat small intestine. Anat. Rec., A. Discov. Mol. Cell. Evol. Biol. 271 (2003) 209-216
50. Shinozaki H., Miyasaka K., Wakasugi H., Fujii N., and Funakoshi A. Bioactivity of synthetic human cholecystokinin (CCK)-33 in vitro and in vivo. Gastroenterol. Jpn. 26 (1991) 51-55
51. Skidgel R.A., and Erdos E.G. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Peptides 25 (2004) 521-525
52. Solomon T.E., Yamada T., Elashoff J., Wood J., and Beglinger C. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33. Am. J. Physiol. 247 (1984) G105-G111
53. Strunz U.T., Thompson M.R., Elashoff J., and Grossman M.I. Hepatic inactivation of gastrins of various chain lengths in dogs. Gastroenterology 74 (1978) 550-553
54. Vagne M., and Grossman M.I. Cholecystokinetic potency of gastrointestinal hormones and related peptides. Am. J. Physiol. 215 (1968) 881-884
55. Villanueva M.L., Collins S.M., Jensen R.T., and Gardner J.D. Structural requirements for action of cholecystokinin on enzyme secretion from pancreatic acini. Am. J. Physiol. 242 (1982) G416-G422
56. Webb T., Gulley S., Esdaile A.R., Pruitt F., Sharma S.K., Williams C.S., and Sayegh A.I. Effects of cholecystokinin-receptor antagonists on Fos-like immunoreactivity stimulated by sulfated cholecystokinin-8 in neurons of the myenteric plexus and hindbrain of rats. Am. J. Vet. Res. 66 (2005) 1308-1313
57. Webb T., Gulley S., Pruitt F., Esdaile A.R., Sharma S.K., Cox J.E., Smith G.P., and Sayegh A.I. Cholecystokinin-8 increases Fos-like immunoreactivity in myenteric neurons of the duodenum and jejunum more after intraperitoneal than after intravenous injection. Neurosci. Lett. 389 (2005) 157-162
58. Zittel T.T., Glatzle J., Kreis M.E., Starlinger M., Eichner M., Raybould H.E., Becker H.D., and Jehle E.C. C-fos protein expression in the nucleus of the solitary tract correlates with cholecystokinin dose injected and food intake in rats. Brain Res. 846 (1999) 1-11